Anika to Participate in the Sidoti Small Cap Virtual Investor Conference

Rhea-AI Summary

Anika Therapeutics, a global leader in joint preservation, has announced its participation in the Sidoti Small Cap Virtual Investor Conference on March 22, 2023, at 9:15 AM ET. The event will feature a virtual presentation from management, followed by a Q&A session. Interested investors can access the webcast through Anika's Investor Relations section on their website, where an archive of the presentation will also be made available. Anika focuses on early intervention orthopedic care, offering innovative solutions for osteoarthritis pain management and soft tissue repair.

News Market Reaction – ANIK

+2.64%

+2.64% Session move

In the trading session that priced this news, ANIK gained 2.64%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BEDFORD, Mass., March 15, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will participate in the Sidoti Small Cap Virtual Investor Conference on Wednesday, March 22, 2023. Anika will host a virtual presentation with Q&A starting at 9:15am ET.

Webcast of the presentation and Q&A will be available in the Investor Relations section of Anika’s website, www.anika.com. An archive of the presentation will also be available on the website.

About Anika
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Leveraging our core expertise in hyaluronic acid and implant solutions, we partner with clinicians to provide minimally invasive products that restore active living for people around the world. Our focus is on high opportunity spaces within orthopedics, including osteoarthritis pain management, regenerative solutions, sports medicine soft tissue repair and bone preserving joint technologies, and our products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika’s global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit www.anika.com.

ANIKA, ANIKA THERAPEUTICS and the Anika logo are registered trademarks of Anika Therapeutics, Inc.

For Investor Inquiries:
Anika Therapeutics, Inc.
Mark Namaroff, 781-457-9287
Vice President, Investor Relations, ESG and Corporate Communications
investorrelations@anika.com

FAQ

When is Anika Therapeutics participating in the Sidoti Small Cap Virtual Investor Conference?

Anika Therapeutics will participate in the Sidoti Small Cap Virtual Investor Conference on March 22, 2023, starting at 9:15 AM ET.

Where can I watch the Anika Therapeutics virtual presentation?

The virtual presentation by Anika Therapeutics can be accessed in the Investor Relations section of their website.

What focus does Anika Therapeutics have in orthopedic care?

Anika Therapeutics specializes in early intervention orthopedic care, including osteoarthritis pain management and regenerative solutions.

What type of products does Anika Therapeutics offer?

Anika Therapeutics offers minimally invasive products that focus on joint preservation and recovery in orthopedics.

What is the stock symbol for Anika Therapeutics?

The stock symbol for Anika Therapeutics is ANIK.